In September 2024, UCB and Biogen reported successful results from their Phase III clinical trial of the PHOENYCS GO study, which tested dapirolizumab pegol as a treatment for moderate-to-severe ...

Researchers from Queen Mary University of London and the University of Nottingham have developed a biocooperative material ...

The study is the main result of Eva Barcelona's Ph.D. thesis and represents a step forward in the development of materials that can guide tissue regeneration with greater precision, laying the ...

The redesigned lineup includes nutritional products for weight management, wellness, muscle and tissue repair, anti-aging for humans and Paw Partners, each developed with advanced scientific research ...

The market for multiplex biomarker imaging is anticipated to reach a valuation of USD 1,631.4 million by 2034, up from USD ...

Nufarm has announced the establishment of strategic R&D partnerships to further expand its bioenergy and sustainable oils ...

Good afternoon, ladies and gentlemen and welcome to the Tela Bio third quarter, 2024. (Operators Instruction). I would now like to turn the conference over to Louisa Smith from the Gilmartin Group.

The global cancer tissue diagnostic market is on track for significant growth, with a projected increase from USD 15,302.2 ...

POLK expression in neurons and report an important observation that POLK exhibits an age-dependent change in subcellular localization, from the nucleus in young tissue to the cytoplasm in old tissue.

Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today reported financial results for the ...